Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: lizard lick who wrote (40954)	7/14/1999 5:45:00 PM
From: Lola	Respond to of 122087

lol... well that is very different from a cure for the common cold.... somebody went a little nuts with this idea it seems. Lola:)

To: lizard lick who wrote (40954)	7/14/1999 7:14:00 PM
From: heronwater	Respond to of 122087

>>Its really for severe complications from cold and flu like cases,,<< Glaxo Wellcome actually has a product (Relenza), that may prevent the onset of the flu virus and more drugs in the pipeline. GLX and other major pharmaceuticals with drugs in the pipeline, have come down quite bit in recent weeks. Why look for value in the majors, when you can chase a VPHM, who has a dream of curing the common cold in the year 2001? BWDIK, besides not wanting to lose money on a bio-tech?